6k67 - Revision history

OCA at 10:27, 22 November 2023

2023-11-22T10:27:12Z

←Older revision		Revision as of 10:27, 22 November 2023
Line 3:		Line 3:
	<StructureSection load='6k67' size='340' side='right'caption='[[6k67]], [[Resolution\|resolution]] 1.95Å' scene=''>		<StructureSection load='6k67' size='340' side='right'caption='[[6k67]], [[Resolution\|resolution]] 1.95Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6k67]] is a 4 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K67 OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6K67 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6k67]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K67 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6K67 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.95Å</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6k67 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k67 OCA], [~~http~~://pdbe.org/6k67 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6k67 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6k67 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6k67 ProSAT]</span></td></tr>	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6k67 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k67 OCA], [https://pdbe.org/6k67 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6k67 RCSB], [https://www.ebi.ac.uk/pdbsum/6k67 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6k67 ProSAT]</span></td></tr>
	</table>		</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/CALM3_HUMAN CALM3_HUMAN] Catecholaminergic polymorphic ventricular tachycardia;Romano-Ward syndrome. The disease may be caused by variants affecting the gene represented in this entry. The disease is caused by variants affecting the gene represented in this entry.
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/CALM3_HUMAN CALM3_HUMAN] Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:31454269). Calcium-binding is required for the activation of calmodulin (PubMed:35568036, PubMed:16760425, PubMed:31454269). Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases, such as myosin light-chain kinases and calmodulin-dependent protein kinase type II (CaMK2), and phosphatases (PubMed:16760425, PubMed:35568036). Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis (PubMed:16760425).<ref>PMID:16760425</ref> <ref>PMID:31454269</ref> <ref>PMID:35568036</ref> (Microbial infection) Required for C.violaceum CopC arginine ADP-riboxanase activity.<ref>PMID:35338844</ref> <ref>PMID:35446120</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 16:		Line 21:
	</div>		</div>
	<div class="pdbe-citations 6k67" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 6k67" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Antibody 3D structures\|Antibody 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Cho~~, G Y~~]]	+	[[Category: Cho GY]]
-	[[Category: Jin~~, M S~~]]	+	[[Category: Jin MS]]
-	[[Category: Kim~~, J W~~]]	+	[[Category: Kim JW]]
-	[[Category: Kim, S]]	+	[[Category: Kim S]]
-	[[Category: Lee, H]]	+	[[Category: Lee H]]
-	[[Category: Lee~~, J O]]~~	+	[[Category: Lee JO]]
-	~~[[Category: Antibody]]~~	+
-	~~[[Category: Protein design]]~~	+
-	~~[[Category: Structural protein~~]]	+

OCA at 15:58, 28 August 2019

2019-08-28T15:58:02Z

←Older revision		Revision as of 15:58, 28 August 2019
Line 3:		Line 3:
	<StructureSection load='6k67' size='340' side='right'caption='[[6k67]], [[Resolution\|resolution]] 1.95Å' scene=''>		<StructureSection load='6k67' size='340' side='right'caption='[[6k67]], [[Resolution\|resolution]] 1.95Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6k67]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K67 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6K67 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6k67]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K67 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6K67 FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6k67 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k67 OCA], [http://pdbe.org/6k67 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6k67 RCSB], [http://www.ebi.ac.uk/pdbsum/6k67 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6k67 ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6k67 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k67 OCA], [http://pdbe.org/6k67 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6k67 RCSB], [http://www.ebi.ac.uk/pdbsum/6k67 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6k67 ProSAT]</span></td></tr>
Line 20:		Line 20:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Cho, G Y]]		[[Category: Cho, G Y]]

OCA at 16:34, 14 August 2019

2019-08-14T16:34:57Z

←Older revision		Revision as of 16:34, 14 August 2019
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6k67 is ~~ON HOLD until Paper~~ Publication	+	==Application of anti-helix antibodies in protein structure determination (9011-3LRH)==
		+	<StructureSection load='6k67' size='340' side='right'caption='[[6k67]], [[Resolution\|resolution]] 1.95Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[6k67]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6K67 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6K67 FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6k67 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6k67 OCA], [http://pdbe.org/6k67 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6k67 RCSB], [http://www.ebi.ac.uk/pdbsum/6k67 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6k67 ProSAT]</span></td></tr>
		+	</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Antibodies are indispensable tools in protein engineering and structural biology. Antibodies suitable for structural studies should recognize the 3-dimensional (3D) conformations of target proteins. Generating such antibodies and characterizing their complexes with antigens take a significant amount of time and effort. Here, we show that we can expand the application of well-characterized antibodies by "transplanting" the epitopes that they recognize to proteins with completely different structures and sequences. Previously, several antibodies have been shown to recognize the alpha-helical conformation of antigenic peptides. We demonstrate that these antibodies can be made to bind to a variety of unrelated "off-target" proteins by modifying amino acids in the preexisting alpha helices of such proteins. Using X-ray crystallography, we determined the structures of the engineered protein-antibody complexes. All of the antibodies bound to the epitope-transplanted proteins, forming accurately predictable structures. Furthermore, we showed that binding of these antihelix antibodies to the engineered target proteins can modulate their catalytic activities by trapping them in selected functional states. Our method is simple and efficient, and it will have applications in protein X-ray crystallography, electron microscopy, and nanotechnology.

-	~~Authors: Lee, J.O~~., ~~Jin~~, M.S., ~~Kim~~, ~~J.W.~~, Kim~~, S.~~, Lee, H., ~~Cho~~, G.Y.	+	Application of antihelix antibodies in protein structure determination.,Kim JW, Kim S, Lee H, Cho G, Kim SC, Lee H, Jin MS, Lee JO Proc Natl Acad Sci U S A. 2019 Aug 1. pii: 1910080116. doi:, 10.1073/pnas.1910080116. PMID:31371498<ref>PMID:31371498</ref>

-	~~Description: Application~~ of ~~anti~~-~~helix antibodies in protein structure determination (9011~~-~~3LRH)~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
		+	<div class="pdbe-citations 6k67" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Cho, G Y]]
		+	[[Category: Jin, M S]]
		+	[[Category: Kim, J W]]
	[[Category: Kim, S]]		[[Category: Kim, S]]
-	[[Category: Lee, J.O]]
	[[Category: Lee, H]]		[[Category: Lee, H]]
-	[[Category: ~~Kim~~, J.W]]	+	[[Category: Lee, J O]]
-	[[Category: ~~Jin, M.S~~]]	+	[[Category: Antibody]]
-	[[Category: ~~Cho, G.Y~~]]	+	[[Category: Protein design]]
		+	[[Category: Structural protein]]

OCA at 04:02, 3 July 2019

2019-07-03T04:02:01Z

←Older revision		Revision as of 04:02, 3 July 2019
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 6k67 is ON HOLD	+	The entry 6k67 is ON HOLD until Paper Publication

	Authors: Lee, J.O., Jin, M.S., Kim, J.W., Kim, S., Lee, H., Cho, G.Y.		Authors: Lee, J.O., Jin, M.S., Kim, J.W., Kim, S., Lee, H., Cho, G.Y.

OCA: Protected "6k67" [edit=sysop:move=sysop]

2019-06-12T03:53:31Z

Protected "6k67" [edit=sysop:move=sysop]

←Older revision

Revision as of 03:53, 12 June 2019

OCA: New page: '''Unreleased structure''' The entry 6k67 is ON HOLD Authors: Lee, J.O., Jin, M.S., Kim, J.W., Kim, S., Lee, H., Cho, G.Y. Description: Application of anti-helix antibodies in protein ...

2019-06-12T03:53:30Z

New page: '''Unreleased structure''' The entry 6k67 is ON HOLD Authors: Lee, J.O., Jin, M.S., Kim, J.W., Kim, S., Lee, H., Cho, G.Y. Description: Application of anti-helix antibodies in protein ...

New page

'''Unreleased structure'''

The entry 6k67 is ON HOLD

Authors: Lee, J.O., Jin, M.S., Kim, J.W., Kim, S., Lee, H., Cho, G.Y.

Description: Application of anti-helix antibodies in protein structure determination (9011-3LRH)
[[Category: Unreleased Structures]]
[[Category: Kim, S]]
[[Category: Lee, J.O]]
[[Category: Lee, H]]
[[Category: Kim, J.W]]
[[Category: Jin, M.S]]
[[Category: Cho, G.Y]]